REDUCTION OF PHENOXYL RADICALS OF THE ANTITUMOR AGENT ETOPOSIDE (VP-16) BY GLUTATHIONE AND PROTEIN SULFHYDRYLS IN HUMAN LEUKEMIA-CELLS - IMPLICATIONS FOR CYTOTOXICITY
Jc. Yalowich et al., REDUCTION OF PHENOXYL RADICALS OF THE ANTITUMOR AGENT ETOPOSIDE (VP-16) BY GLUTATHIONE AND PROTEIN SULFHYDRYLS IN HUMAN LEUKEMIA-CELLS - IMPLICATIONS FOR CYTOTOXICITY, Toxicology in vitro, 10(1), 1996, pp. 59-68
Phenoxyl radicals are inevitable intermediates in the oxidative enzyma
tic metabolism of a phenolic antitumour drug, etoposide (VP-16), by pe
roxidases, cytochrome P-450, prostaglandin synthetase and tyrosinase,
as well as in its interactions with oxygen and peroxyl radicals. It ha
s been shown that one-electron reduction of the VP-16 phenoxyl radical
by ascorbate and thiols prevents/delays its oxidative metabolism by t
yrosinase both in model systems and in cell homogenates. To elucidate
the role of endogenous thiols in the reduction of VP-16 phenoxyl radic
als, K562 human leukaemia cells grown in Dulbecco's modified Eagle's m
edium which does not contain vitamin C (ascorbate) were used, thus exc
luding the ascorbate-dependent reduction of VP-16 phenoxyl radicals. V
P-16 phenoxyl radicals were reduced by endogenous reductants in K562 c
ell homogenates, intracellular thiols mainly being responsible. Deplet
ion of endogenous thiols by mersalyl acid resulted in almost complete
inhibition of the ability of cell homogenates to reduce VP-16 phenoxyl
radicals. Three systems were used to evaluate the contribution of thi
ol-dependent reduction of VP-16 phenoxyl radicals: (1) K562 cell homog
enates depleted or supplemented with glutathione (GSH) in vitro; (2) h
omogenates derived from K562 cells with a decreased level of endogenou
s thiols and GSH (using a specific inhibitor of gamma-glutamyl cystein
e synthetase, buthionine-S,R-sulfoximine; BSO) and (3) homogenates der
ived from K562 cells with increased content of endogenous thiols as a
result of treatment with cadmium chloride. Depletion of thiols in K562
cells or cell homogenates proportionally decreased the ability of hom
ogenates to reduce VP-16 phenoxyl radicals. Similarly, depletion or su
pplementation of K562 cells or cell homogenates with GSH proportionall
y decreased or increased the ability to reduce VP-16 phenoxyl radicals
. Reduction of VP-16 phenoxyl radicals by K562 cell homogenates was si
milar to that obtained from cell homogenates isolated from K/VP.5 cell
s, a VP-16 resistant cell line derived from K562 cells. Elevation of e
ndogenous thiols by cadmium chloride increased the ability of homogena
tes to reduce VP-16 phenoxyl radicals but did not reveal any significa
nt difference in the ability of the two types of cells to interact wit
h VP-16 radicals. Finally, BSO treatment of K562 cells led to potentia
tion of VP-16-induced DNA damage and to an increase in VP-16-induced g
rowth inhibition, suggesting that, in the absence of ascorbate, modula
tion of endogenous thiols may be an important factor determining the o
xidative metabolism and cytotoxic activity of VP-16 in tumour cells.